Fmr LLC Decreases Stock Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

Fmr LLC cut its stake in LifeStance Health Group, Inc. (NASDAQ:LFST) by 15.6% in the third quarter, Holdings Channel.com reports. The firm owned 36,812,825 shares of the company’s stock after selling 6,807,852 shares during the quarter. Fmr LLC owned approximately 0.10% of LifeStance Health Group worth $257,690,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its stake in shares of LifeStance Health Group by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 7,668,966 shares of the company’s stock worth $47,318,000 after acquiring an additional 95,197 shares during the last quarter. Principal Financial Group Inc. raised its stake in LifeStance Health Group by 6.1% during the third quarter. Principal Financial Group Inc. now owns 4,116,766 shares of the company’s stock worth $28,817,000 after purchasing an additional 235,316 shares during the period. Jennison Associates LLC raised its stake in LifeStance Health Group by 9.5% during the third quarter. Jennison Associates LLC now owns 2,136,942 shares of the company’s stock worth $14,959,000 after purchasing an additional 184,896 shares during the period. Charles Schwab Investment Management Inc. grew its stake in shares of LifeStance Health Group by 36.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,104,453 shares of the company’s stock valued at $7,731,000 after buying an additional 297,723 shares during the period. Finally, Dimensional Fund Advisors LP grew its stake in shares of LifeStance Health Group by 82.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,016,452 shares of the company’s stock valued at $4,991,000 after buying an additional 457,930 shares during the period. Hedge funds and other institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Stock Up 0.1 %

LifeStance Health Group stock opened at $7.52 on Monday. The company has a market capitalization of $2.88 billion, a PE ratio of -28.92 and a beta of 1.24. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32. LifeStance Health Group, Inc. has a fifty-two week low of $4.64 and a fifty-two week high of $9.20. The firm has a 50 day moving average price of $7.09 and a 200 day moving average price of $6.28.

LifeStance Health Group (NASDAQ:LFST) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.05. LifeStance Health Group had a negative return on equity of 6.66% and a negative net margin of 7.90%. The firm had revenue of $312.70 million for the quarter, compared to the consensus estimate of $302.25 million. During the same quarter in the previous year, the business earned ($0.17) EPS. The company’s quarterly revenue was up 18.9% compared to the same quarter last year. Research analysts expect that LifeStance Health Group, Inc. will post -0.22 earnings per share for the current year.

Analyst Upgrades and Downgrades

LFST has been the topic of a number of recent analyst reports. UBS Group decreased their price objective on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating on the stock in a report on Thursday, August 15th. Barclays upped their price target on LifeStance Health Group from $6.00 to $7.00 and gave the company an “underweight” rating in a research note on Monday, November 11th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $8.50.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.